Rybelsus® reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2 diabetes and cardiovascular and ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

Cardiology stocks will be back in the spotlight this weekend when the American College of Cardiology's annual scientific ...

Novo Nordisk (NVO) says its obesity drug Ozempic improved walking distance for diabetes patients with peripheral artery ...

Lexicon Pharmaceuticals Inc. said March 28 it will exclusively license its drug candidate LX9851 to Danish pharmaceutical ...

Developers of cardiology drugs and devices will be back in the spotlight this weekend when the annual scientific meeting of ...

Target has announced it will reduce bonuses for salaried employees due to weak consumer spending and inflationary pressures.

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top ...